Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cell Culture Reagents Market worth $8.95 billion by 2030 | MarketsandMarkets™

      This image opens in the lightbox

      News provided by

      MarketsandMarkets

      06 Jan, 2026, 15:30 GMT

      Share this article

      Share this article


      DELRAY BEACH, Fla., Jan. 6, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Cell Culture Reagents Market is projected to grow from about USD 5.06 billion in 2025 to USD 8.95 billion by 2030, at a CAGR of 12.1%.

      Browse through 600 market data tables and 45 figures spread across 650 Pages and in-depth TOC on "Cell Culture Reagents Market - Global Forecast to 2030

      Cell Culture Reagents Market Size & Forecast:

      • Market Size Available for Years: 2024–2030
      • 2025 Market Size: USD 5.06 billion
      • 2030 Projected Market Size: USD 8.95 billion
      • CAGR (2025–2030): 12.1%

      Cell Culture Reagents Market Trends & Insights:

      • The cell culture reagents market growth factors segment is expected to dominate the market in 2024.
      • The biopharmaceutical production segment is projected to grow at the fastest rate from 2025 to 2030.
      • The pharmaceutical & biotechnology companies' segment is projected to grow at the fastest rate from 2025 to 2030.
      • The North America cell culture reagents market accounted for a 39.6% revenue share in 2024.

      Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52737241 

      The global cell culture reagents market is expected to grow rapidly, as these products are widely utilized in various cell-based technologies, including biopharmaceutical manufacturing, drug discovery, and other applications. Because cell culture is a complex process, the need for high-quality reagents has increased to ensure the proper preservation of the cells. Furthermore, the adoption and requirements for regulating research and manufacturing have contributed significantly to the growth in demand for reagents in the cell culture reagents market. Apart from these factors, research expenditure in the life sciences has been the primary factor influencing the market's progression. 

      Key players are offering high-purity, chemically defined reagents, including growth factors, supplements, and matrix components, to meet regulatory requirements and performance needs. Companies are also focusing on process-specific reagent development, quality assurance, and supply chain flexibility to support large-scale, GMP-compliant manufacturing.

      By Type, the growth factors segment is expected to register the fastest growth during the forecast period of 2025 to 2030.

      the cell culture reagents market is divided into growth factors, supplements, buffers & chemicals, cell dissociation reagents, balanced salt solutions, attachment & matrix factors, antibiotics/antimycotics, cryoprotective reagents, contamination detection kits, and other cell culture reagents. This is driven by the rapid scale-up of cell and gene therapy programs, in which growth factors and cytokines are repeatedly used for cell activation, expansion, and differentiation. Adoption is also rising in stem cell, organoid, and iPSC workflows, where defined growth-factor cocktails are essential for consistent outcomes.

      Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=52737241

      By end user, the pharmaceutical & biotechnology companies segment is expected to be the largest segment in the cell culture reagents market.

      the market for cell culture reagents has been segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical and biotechnology companies segment accounted for the largest share of the market in 2024 and is also the fastest-growing end-user segment. Growth is supported by an expanding biologics pipeline and a higher number of programs moving from development into clinical and commercial manufacturing, which drive repeat consumption of media, feeds, supplements, and buffers across the seed train and production.

      The Asia Pacific is expected to be the fastest-growing region in the global cell culture reagents market during the forecast period.

      The global cell culture reagents market is segmented by region into North America, Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. The Asia-Pacific region is experiencing significant growth. The main reasons for this are the large investments in Singapore, such as AbbVie's biologics capacity expansion and Novartis' antibody manufacturing expansion with automation, which are driving steady and increasing demand for media, feeds, supplements, and buffers at the production scale. Therefore, as biomanufacturing capacity is distributed across different hubs, the region is likely to experience significant growth.

      Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=52737241

      Top Companies in Cell Culture Reagents Market:

      The Top Companies in Cell Culture Reagents Market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), and Sartorius AG (Germany), among others.

      Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

      Related Reports:

      Cell Culture Vessels Market - Global Forecast to 2030

      Cell Culture Market - Global Forecast to 2030

      3D Cell Culture Market - Global Forecast to 2030

      Cell Based Assays Market - Global Forecast to 2030

      Cell Expansion Market - Global Forecast to 2029

      About MarketsandMarkets™ 

      MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

      MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

      Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

      The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

      Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

      To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

      Contact:
      Mr. Rohan Salgarkar
      MarketsandMarkets™ INC.
      1615 South Congress Ave.
      Suite 103, Delray Beach, FL 33445
      USA: +1-888-600-6441
      Email: sales@marketsandmarkets.com
      Visit Our Website: https://www.marketsandmarkets.com/

      Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

      Modal title

      Also from this source

      Healthcare Quality Management (QMS) Market worth $2.81 billion by 2031 - Exclusive Report by MarketsandMarkets™

      Healthcare Quality Management (QMS) Market worth $2.81 billion by 2031 - Exclusive Report by MarketsandMarkets™

      According to MarketsandMarkets™, the Healthcare Quality Management (QMS) Market is projected to reach USD 2.81 billion by 2031 from USD 1.60 billion...

      Identity Verification Market worth $33.36 billion by 2031 - Report by MarketsandMarkets™

      Identity Verification Market worth $33.36 billion by 2031 - Report by MarketsandMarkets™

      According to MarketsandMarkets™, the Identity Verification Market is projected to grow from USD 16.48 billion in 2026 to USD 33.36 billion by 2031 at ...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Biotechnology

      Biotechnology

      Chemical

      Chemical

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.